18F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
Introduction. PET imaging is a useful clinical tool for studying tumor progression and treatment effects. Conventional 18F-FDG-PET imaging is of limited usefulness for imaging Glioblastoma Multiforme (GBM) due to high levels of glucose uptake by normal brain and the resultant signal-to-noise intensi...
Main Authors: | Sanjay Chandrasekaran, Andrew Hollander, Xiangsheng Xu, Joseph L. Benci, James J. Davis, Jay F. Dorsey, Gary Kao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2013/796029 |
Similar Items
-
Differences in tumor volume for treated glioblastoma patients examined with 18F-fluorothymidine PET and contrast-enhanced MRI
by: Hedman, Karolina
Published: (2020) -
Additional Value of 18F-FDOPA Amino Acid Analog Radiotracer to Irradiation Planning Process of Patients With Glioblastoma Multiforme
by: David Sipos, et al.
Published: (2021-07-01) -
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
by: Peter K. Wong, et al.
Published: (2014-05-01) -
Predicting future morphological changes of lesions from radiotracer uptake in 18F-FDG-PET images.
by: Ulas Bagci, et al.
Published: (2013-01-01) -
Biomarkers of Glioblastoma Multiforme
by: Guru Dutta Satyarthee, et al.
Published: (2018-09-01)